Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 100

1.

Partial Gland Ablation for Prostate Cancer: Report of a Food and Drug Administration, American Urological Association, and Society of Urologic Oncology Public Workshop.

Jarow JP, Ahmed HU, Choyke PL, Taneja SS, Scardino PT.

Urology. 2016 Feb;88:8-13. doi: 10.1016/j.urology.2015.11.018. Epub 2015 Nov 24.

PMID:
26621480
2.

Drug and device development for localized prostate cancer: report of a Food and Drug Administration/American Urological Association public workshop.

Jarow JP, Thompson IM, Kluetz PG, Baxley J, Sridhara R, Scardino P, Carroll P, Albertsen P, Carter HB, Brawley O, Sartor O, Sandler H, Kiefert JJ, Morton RA Jr.

Urology. 2014 May;83(5):975-8. doi: 10.1016/j.urology.2013.10.087. Epub 2014 Mar 22.

PMID:
24661332
3.

Clinical trial design for the development of new therapies for nonmuscle-invasive bladder cancer: report of a Food and Drug Administration and American Urological Association public workshop.

Jarow JP, Lerner SP, Kluetz PG, Liu K, Sridhara R, Bajorin D, Chang S, Dinney CP, Groshen S, Morton RA, O'Donnell M, Quale DZ, Schoenberg M, Seigne J, Vikram B.

Urology. 2014 Feb;83(2):262-4. doi: 10.1016/j.urology.2013.10.030. Epub 2013 Dec 12.

PMID:
24332121
4.

Developments in urologic oncology 'OncoForum': The best of 2014.

Gómez-Veiga F, Alcaraz-Asensio A, Burgos-Revilla J, Cózar-Olmo J.

Actas Urol Esp. 2015 Jun;39(5):271-8. doi: 10.1016/j.acuro.2015.02.004. Epub 2015 Mar 12. English, Spanish.

PMID:
25770399
5.

Executive Summary of the National Cancer Institute Workshop: Highlights and recommendations.

Lieberman R, Nelson WG, Sakr WA, Meyskens FL Jr, Klein EA, Wilding G, Partin AW, Lee JJ, Lippman SM.

Urology. 2001 Apr;57(4 Suppl 1):4-27.

PMID:
11295590
6.

Robotic-assisted minimally invasive surgery for gynecologic and urologic oncology: an evidence-based analysis.

Health Quality Ontario.

Ont Health Technol Assess Ser. 2010;10(27):1-118. Epub 2010 Dec 1.

7.

Indications for and anatomical extent of pelvic lymph node dissection for prostate cancer: practice patterns of uro-oncologists in North America.

Touijer KA, Ahallal Y, Guillonneau BD.

Urol Oncol. 2013 Nov;31(8):1517-21.e1-2. doi: 10.1016/j.urolonc.2012.04.021. Epub 2012 Jun 9.

PMID:
22687569
8.

Variation in the definition of biochemical recurrence in patients treated for localized prostate cancer: the American Urological Association Prostate Guidelines for Localized Prostate Cancer Update Panel report and recommendations for a standard in the reporting of surgical outcomes.

Cookson MS, Aus G, Burnett AL, Canby-Hagino ED, D'Amico AV, Dmochowski RR, Eton DT, Forman JD, Goldenberg SL, Hernandez J, Higano CS, Kraus SR, Moul JW, Tangen C, Thrasher JB, Thompson I.

J Urol. 2007 Feb;177(2):540-5. Review.

PMID:
17222629
9.

NIH State-of-the-Science Conference Statement: Role of active surveillance in the management of men with localized prostate cancer.

Ganz PA, Barry JM, Burke W, Col NF, Corso PS, Dodson E, Hammond ME, Kogan BA, Lynch CF, Newcomer L, Seifter EJ, Tooze JA, Viswanath KV, Wessells H.

NIH Consens State Sci Statements. 2011 Dec 5-7;28(1):1-27.

PMID:
23392076
10.

Is it necessary to remove the seminal vesicles completely at radical prostatectomy? decision curve analysis of European Society of Urologic Oncology criteria.

Secin FP, Bianco FJ, Cronin A, Eastham JA, Scardino PT, Guillonneau B, Vickers AJ; European Society of Urologic Oncology.

J Urol. 2009 Feb;181(2):609-13; discussion 614. doi: 10.1016/j.juro.2008.10.035. Epub 2008 Dec 13.

12.

Current followup strategies after radical prostatectomy: a survey of American Urological Association urologists.

Oh J, Colberg JW, Ornstein DK, Johnson ET, Chan D, Virgo KS, Johnson FE.

J Urol. 1999 Feb;161(2):520-3.

PMID:
9915439
13.

The role of magnetic resonance imaging (MRI) in focal therapy for prostate cancer: recommendations from a consensus panel.

Muller BG, Fütterer JJ, Gupta RT, Katz A, Kirkham A, Kurhanewicz J, Moul JW, Pinto PA, Rastinehad AR, Robertson C, de la Rosette J, Sanchez-Salas R, Jones JS, Ukimura O, Verma S, Wijkstra H, Marberger M.

BJU Int. 2014 Feb;113(2):218-27. doi: 10.1111/bju.12243. Epub 2013 Nov 13.

14.

Clinical trial endpoints in ovarian cancer: report of an FDA/ASCO/AACR Public Workshop.

Bast RC, Thigpen JT, Arbuck SG, Basen-Engquist K, Burke LB, Freedman R, Horning SJ, Ozols R, Rustin GJ, Spriggs D, Wenzel LB, Pazdur R.

Gynecol Oncol. 2007 Nov;107(2):173-6.

PMID:
17950384
16.

Highlights from the Society of Urologic Oncology, 5th Annual Meeting, December 3-4, 2004, Bethesda, Maryland, United States of America.

Grubb RL 3rd, Behari A, Kim CM, Williams CR, Linehan WM, Coleman JA.

J Urol. 2005 Dec;174(6):2330-3.

PMID:
16280834
17.

The past, present and future of minimally invasive therapy in urology: a review and speculative outlook.

Rassweiler J, Rassweiler MC, Kenngott H, Frede T, Michel MS, Alken P, Clayman R.

Minim Invasive Ther Allied Technol. 2013 Aug;22(4):200-9. doi: 10.3109/13645706.2013.816323. Epub 2013 Jun 30. Review.

PMID:
23808367
18.

Best practices in robot-assisted radical prostatectomy: recommendations of the Pasadena Consensus Panel.

Montorsi F, Wilson TG, Rosen RC, Ahlering TE, Artibani W, Carroll PR, Costello A, Eastham JA, Ficarra V, Guazzoni G, Menon M, Novara G, Patel VR, Stolzenburg JU, Van der Poel H, Van Poppel H, Mottrie A; Pasadena Consensus Panel.

Eur Urol. 2012 Sep;62(3):368-81. doi: 10.1016/j.eururo.2012.05.057. Epub 2012 Jun 7. Review.

PMID:
22763081
19.

Adjuvant and salvage radiation therapy after prostatectomy: American Society for Radiation Oncology/American Urological Association guidelines.

Valicenti RK, Thompson I Jr, Albertsen P, Davis BJ, Goldenberg SL, Wolf JS, Sartor O, Klein E, Hahn C, Michalski J, Roach M 3rd, Faraday MM; American Society for Radiation Oncology/American Urological Association.

Int J Radiat Oncol Biol Phys. 2013 Aug 1;86(5):822-8. doi: 10.1016/j.ijrobp.2013.05.029. Review.

PMID:
23845839
20.

Candidate selection for quadrant-based focal ablation through a combination of diffusion-weighted magnetic resonance imaging and prostate biopsy.

Matsuoka Y, Numao N, Saito K, Tanaka H, Kumagai J, Yoshida S, Ishioka J, Koga F, Masuda H, Kawakami S, Fujii Y, Kihara K.

BJU Int. 2016 Jan;117(1):94-101. doi: 10.1111/bju.12901. Epub 2015 May 24.

Supplemental Content

Support Center